В глобольном МсК большой разбор полетов после опиоидов. Вероятно, продолжать его будет новый директор. Узнаем в ближайшие недели.

Интересная вырезка из последней статьи ft.com. Tldr: опиоидный кризис - не косяк пары партнёров, как в случае с инсайдерским трейдингом 12 лет назад. Тут косяки на уровне компании.

"McKinsey worked for Purdue for more than 15 years, between 2004 and 2019, long after its client’s 2007 guilty plea and $634m fine for felony misbranding.

Moreover, it collected millions of dollars designing and implementing marketing campaigns for three other opioid manufacturers — Johnson & Johnson, Endo Pharmaceuticals and Mallinckrodt — the lawsuits found. One presentation released in court showed it suggesting that “high abuse-risk patients” were an “opportunity” for J&J with a patch based on fentanyl, an opioid that is 50 to 100 times more potent than morphine."